An employee was killed and two people were wounded Tuesday in a shooting at a Long Island grocery store. Officials say a person of interest in the shooting had worked at the store and remains at large. (April 20)
An employee was killed and two people were wounded Tuesday in a shooting at a Long Island grocery store. Officials say a person of interest in the shooting had worked at the store and remains at large. (April 20)
(Bloomberg) -- Israel intensified its attacks on high-ranking militant commanders in the Hamas-ruled Gaza Strip, as well as the group’s network of underground tunnels, rebuffing international pleas to halt its onslaught.The Israeli military reported that a top commander in Islamic Jihad, Gaza’s second-largest militant group, had been killed in the heavy aerial and artillery attacks on Monday, which Israel characterized as strikes on terrorist infrastructure and weapons storage locations. Hamas continued to rain rocket fire on civilian targets in Israel as the fighting entered its second week.Israeli Prime Minister Benjamin Netanyahu vowed on Sunday that Israel would continue to pummel the isolated Palestinian enclave, where about 200 people have been killed since hostilities began last Monday. Gaza health officials say more than 50 children are among the dead.Ten people, including a child, have been killed inside Israel, where the lethality of the thousands of rockets fired has been tempered by a missile-defense system that’s intercepted many projectiles before they land.“Our campaign against the terrorist organizations is continuing with full force,” Netanyahu said on Sunday, noting that Israeli warplanes have struck 1,500 targets in the Palestinian territory. The operation “will yet take time,” he said.World Demands Gaza Cease-Fire as Netanyahu Vows to Press On The U.S. and other world powers have called for an end to the violence in Israel and in Gaza. The United Nations Security Council met virtually in an emergency session on Sunday. The U.S. has been working with Egypt and Qatar to try to broker a cease-fire, and its envoy met with Palestinian officials on Monday. The fighting has complicated, if not destroyed, Israeli opposition efforts to form a government that would unseat Netanyahu after the fourth round of elections in March again yielded no clear victor. One prospective partner in a potential alternative government pulled out of coalition talks and another has suspended them. Netanyahu, who is on trial for alleged influence-peddling, on Sunday pushed back against suggestions that he’s extending the conflict for his own political gain, calling it “preposterous” in an interview on CBS TV’s Face the Nation program.The hostilities erupted after weeks of clashes between Palestinians and Israeli security forces in east Jerusalem, including over Israeli efforts to expel Arab residents from their longtime homes in the holy city that’s at the heart of conflicting sovereignty claims. They also set off deadly clashes inside Israel between Arab and Jewish citizens that have since been quelled.General strikes have been called for Tuesday in Israeli Arab communities and the West Bank to protest the violence in Gaza and Jerusalem.What’s Behind Surging Israeli-Palestinian Violence: QuickTake|Israel seems intent on inflicting as much damage on Hamas as possible before ending the fighting, and has launched waves of strikes against cross-border tunnels designed for infiltration, and a network of subterranean corridors within Gaza used for combat, transport, weapons storage and as hideouts.It’s also targeted rocket stockpiles, militant command centers and naval and drone capabilities, and assassinated key military and intelligence figures from Hamas, which seized control of the territory in 2007.Some of the attacks have taken place at refugee camps, hospitals and schools, where Israel accuses Hamas of using human shields to try to protect its military operations. Palestinians say many of the victims have been civilians.Power and water supplies have been disrupted, with each side blaming the other for disabling power lines and plunging hundreds of thousands of people in the impoverished territory of more than 2 million people into darkness for hours a day. Sewage from a damaged line was leaking into the Mediterranean, and dozens of main roads and streets have been hammered, making it difficult for ambulances and civil defense forces to navigate.Crossing OpenedThe mayor of Gaza City, Yahya al-Sarraj, said the Israeli strikes deliberately targeted roads to sever links between different areas and destroy the infrastructure in the enclave’s biggest city.Fuel supplies from Israel have been cut off, compromising power at hospitals, ambulance services, a desalination plant and municipal services, Gaza officials said. Mohammed Thabet, a spokesman for the Gaza Electricity Distribution Co., said at a press conference that the utility has enough fuel to operate power stations for only two to three days.Egypt, which along with Israel has been blockading Gaza since 2007, has opened a crossing with it to allow in some of the wounded, Palestinian officials reported.Last week, Israel leveled a high-rise housing media offices of The Associated Press, Al-Jazeera and other news agencies. Media outlets have accused Israel of trying to stifle coverage of the war, and rejected Israel’s claim that Hamas intelligence agents were working in the building.In Israel, daily life has been disrupted for millions of people, mostly in southern communities and central Israel, where thousands of air raid sirens have sent people scurrying repeatedly to seek sanctuary in bomb shelters or stairwells. Dozens of apartments have been damaged, and busy streets and beaches have often been emptied as people in rocket-scarred areas fear to venture outside.According to the military, 3,150 rockets have been fired from Gaza, including 460 that fell short and landed inside the Palestinian territory, sometimes causing casualties there. It said the Iron Dome air defense system has intercepted about 90% of the rockets it’s targeted.The Hamas group’s armed resistance against Israel has scored it points domestically, where it is seen as a more effectual fighter against Israel than the rival West Bank-based Palestinian Authority, headed by President Mahmoud Abbas. After 16 years in power, Abbas has brought the Palestinians no closer to statehood.“Their image was lifted dramatically,” said Ghassan Khatib, a former Palestinian cabinet minister who teaches political science at Birzeit University near Ramallah. Abbas, whose term officially ended in late 2009, called off legislative elections scheduled for May in which Hamas stood to gain, if not win, according to polls.(Updates with Islamic Jihad commander reported killed in second paragraph, comments from Gaza officials from 13th.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Dublin, May 17, 2021 (GLOBE NEWSWIRE) -- The "Vending Machine Market by Type, Application, Technology and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2021-2027" report has been added to ResearchAndMarkets.com's offering. A vending machine is used to dispense the items that are stored inside it, such as packaged food, beverages, and tobacco products, in exchange with inserted coins or tokens. Dispensing is an automated process, which requires no manpower and saves precious time of humans. These machines are normally seen in fast-moving cities due to fast-paced life. Vending machine not only dispenses items but also engages shoppers with the help of touch-screen controls, video, audio, scent, gesture-based interaction, and cashless payment. Furthermore, these products have multiple applications in hotels & restaurants, corporate offices, public places, and others.Increase in demand for food vending machines in offices/institutions, rise in consumption of convenience food items, and the adoption of smart customer service technologies in several food categories are the driving factors for the growth of the market. The global vending machine market was valued at $18.28 billion in 2019 and is anticipated to reach $25.25 billion by 2027, with a CAGR of 6.7% during the forecast period.The demand for machines has increased during the past few years and with the introduction of cashless payment systems, smart technology solutions are gaining momentum on a large scale across the globe. Moreover, increasing urbanization and rising disposable income have fuelled the growth of the vending machine market. Governments of various regions restricted the use of food & beverages vending machines in many places, such as schools and colleges, thereby limiting the demand for these machines. In addition, high initial installation cost of vending machine restraints the growth of the global market.Increasing popularity of vending machines in developed and developing economies and convenience offered to the consumers are the factors augmenting the demand for vending machines. Changing buying habits of customers and demand for a more convenient method for buying food & beverages further propel the growth of the market. Moreover, rising need to expand virtual space in a retail outlet is driving the growth of the vending machine market globally.The vending machine market is segmented on the basis of type, application, technology, sales channel, and region. By type, it is categorized into food vending machine, beverages vending machine, tobacco vending machine, and others. By application, it is segmented into hotels & restaurants, corporate offices, public places, and others. By technology, it is divided into automatic machine, semi-automatic machine, and smart machine. By sales channel, it is bifurcated into online and offline. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Spain, Italy, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, the UAE, Saudi Arabia, Turkey, and Rest of LAMEA).The key players profiled in this report include Sandenvendo America, Inc., Crane Merchandising Systems, Azkoyen Group, Fuji Electric Co., Ltd, Fastcorp Vending LLC, Royal Vendors, Inc., Seaga Manufacturing Inc, Jofemar Corporation., Selecta TMP AG, and Bianchi Industry.Key Benefits The study provides an in-depth analysis of the global vending machine market, with current and future trends to explain the imminent investment pockets in the market.Current and future trends are outlined in the report to determine the overall market attractiveness and single out profitable trends to gain a stronger foothold in the market.The report provides information regarding drivers, restraints, and opportunities with impact analysis.A quantitative analysis of the current market and estimation for the same from 2019 to 2027 is provided to showcase the financial competency of the market.Porter's five forces model of the industry illustrates competitiveness of the market by analyzing various parameters such as threat of new entrants, threat of substitutes, bargaining power of buyers, and bargaining power of suppliers operating in the market.Value chain analysis in the report provides a clear understanding of the roles of stakeholders involved in the value chain.Competitive intelligence highlights the business practices followed by the leading market players across various regions. Key Topics Covered: Chapter 1: Introduction1.1. Key Benefits for Stakeholders1.2. Key Market Segments1.3. Research Methodology1.3.1. Secondary Research1.3.2. Primary Research1.3.3. Analyst Tools and ModelsChapter 2: Executive Summary2.1. Key Findings of the Study2.2. Cxo PerspectiveChapter 3: Market Overview3.1. Market Definition and Scope3.2. Key Findings3.2.1. Top Investment Pockets3.3. Industry Pain Point Analysis3.5. Top Players Positioning3.6. Value Chain Analysis3.7. Porter's Five Forces Analysis3.7.1. Moderate Bargaining Power of Suppliers3.7.2. Moderate Bargaining Power of Buyers3.7.3. Moderate Threat of Substitution3.7.4. Moderate Threat of New Entrants3.7.5. Moderate Intensity of Competitive Rivalry3.8. Market Dynamics3.8.1. Drivers188.8.131.52. Increasing Demand for Food Products due to Hectic Lifestyle of Consumers184.108.40.206. Growing Adoption of Vending Machines to Enhance the Consumer Shopping Experience3.8.2. Restraint220.127.116.11. Prohibition of the Sale of Tobacco Products in Several Regions3.8.3. Opportunities18.104.22.168. Growing Demand for Vending Machines from the Retail Industry Will Offer Immense Growth Opportunities22.214.171.124. Technological Advancement in Vending Machine3.9. Market Share Analysis3.9.1. by Type3.9.2. by Application3.9.3. by Technology3.9.4. by Sales Channel3.9.5. by Region3.10. Pricing Analysis3.11. Impact of COVID-19 on the Vending Machine MarketChapter 4: Vending Machine Market, by Type4.1. Overview4.1.1. Market Size and Forecast, by Type4.2. Food Vending Machine4.2.1. Key Market Trends, Growth Factors, and Opportunities4.2.2. Market Size and Forecast, by Region4.3. Beverages Vending Machine4.3.1. Key Market Trends, Growth Factors, and Opportunities4.3.2. Market Size and Forecast, by Region4.4. Tobacco Vending Machine4.4.1. Key Market Trends, Growth Factors, and Opportunities4.4.2. Market Size and Forecast, by Region4.5. Others Vending Machine4.5.1. Key Market Trends, Growth Factors, and Opportunities4.5.2. Market Size and Forecast, by RegionChapter 5: Vending Machine Market, by Application5.1. Overview5.1.1. Market Size and Forecast, by Application5.2. Hotels & Restaurants5.2.1. Key Market Trends, Growth Factors, and Opportunities5.2.2. Market Size and Forecast, by Region5.3. Corporate Offices5.3.1. Key Market Trends, Growth Factors, and Opportunities5.3.2. Market Size and Forecast, by Region5.4. Public Places5.4.1. Key Market Trends, Growth Factors, and Opportunities5.4.2. Market Size and Forecast, by Region5.5. Others5.5.1. Key Market Trends, Growth Factors, and Opportunities5.5.2. Market Size and Forecast, by RegionChapter 6: Vending Machine Market, by Technology6.1. Overview6.1.1. Market Size and Forecast, by Technology6.2. Automatic Machine6.2.1. Key Market Trends, Growth Factors, and Opportunities6.2.2. Market Size and Forecast, by Region6.3. Semi-Automatic Machine6.3.1. Key Market Trends, Growth Factors, and Opportunities6.3.2. Market Size and Forecast, by Region6.4. Smart Machine6.4.1. Key Market Trends, Growth Factors, and Opportunities6.4.2. Market Size and Forecast, by RegionChapter 7: Vending Machine Market, by Sales Channel7.1. Overview7.1.1. Market Size and Forecast, by Sales Channel7.2. Online7.2.1. Key Market Trends, Growth Factors, and Opportunities7.2.2. Market Size and Forecast, by Region7.3. Offline7.3.1. Key Market Trends, Growth Factors, and Opportunities7.3.2. Market Size and Forecast, by RegionChapter 8: Vending Machine Market, by Region8.1. Overview8.2. North America8.3. Europe8.4. Asia-Pacific8.5. LAMEAChapter 9: Competition Landscape9.1. Top Winning Strategies9.2. Product Mapping9.3. Competitive Dashboard9.4. Competitive Heat Map9.5. Key Developments9.5.1. Acquisition9.5.2. Agreement9.5.3. Product LaunchChapter 10: Company Profiles10.1. Azkoyen Group.10.1.1. Company Overview10.1.2. Key Executives10.1.3. Company Snapshot10.1.4. Operating Business Segments10.1.5. Product Portfolio10.1.6. Key Strategic Moves and Developments10.2. Bianchi Industry Spa10.2.1. Company Overview10.2.2. Key Executives10.2.3. Company Snapshot10.2.4. Product Portfolio10.3. Crane Company.10.3.1. Company Overview10.3.2. Key Executives10.3.3. Company Snapshot10.3.4. Operating Business Segments10.3.5. Product Portfolio10.3.6. R&D Expenditure10.3.7. Business Performance10.4. Fastcorp Vending LLC.10.4.1. Company Overview10.4.2. Key Executives10.4.3. Company Snapshot10.4.4. Product Portfolio10.5. Fuji Electric Co., Ltd.10.5.1. Company Overview10.5.2. Key Executives10.5.3. Company Snapshot10.5.4. Operating Business Segments10.5.5. Product Portfolio10.5.6. R&D Expenditure10.5.7. Business Performance10.5.8. Key Strategic Moves and Developments10.6. Jofemar Corporation.10.6.1. Company Overview10.6.2. Key Executives10.6.3. Company Snapshot10.6.4. Product Portfolio10.7. Royal Vendors, Inc.10.7.1. Company Overview10.7.2. Key Executives10.7.3. Company Snapshot10.7.4. Product Portfolio10.8. Sandenvendo America, Inc.10.8.1. Company Overview10.8.2. Key Executives10.8.3. Company Snapshot10.8.4. Product Portfolio10.8.5. Key Strategic Moves and Developments10.9. Seaga Manufacturing, Inc.10.9.1. Company Overview10.9.2. Key Executives10.9.3. Company Snapshot10.9.4. Product Portfolio10.10. Selecta Group B. V.10.10.1. Company Overview10.10.2. Key Executives10.10.3. Company Snapshot10.10.4. Product Portfolio10.10.5. Business Performance10.10.6. Key Strategic Moves and DevelopmentsFor more information about this report visit https://www.researchandmarkets.com/r/hd5hku CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
LAKE FOREST, Ill., May 17, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it has filed a Certificate of Amendment to its certificate of incorporation (the “Certificate of Amendment”) to implement a one-to-four reverse split of its issued and outstanding common stock (the “Reverse Split”). The Reverse Split will become effective as of 12:01 a.m. Eastern Time on May 18, 2021, and the Company’s common stock will begin trading on a split-adjusted basis when the market opens on May 18, 2021. When the Reverse Split becomes effective, every four shares of the Company’s issued and outstanding common stock will automatically be converted into one share of common stock, without any change in the par value per share. In addition, proportionate adjustments will be made to (i) the per share exercise price and the number of shares issuable upon the exercise of all outstanding stock options and warrants to purchase shares of common stock, (ii) the number of shares issuable upon the vesting of all restricted stock units and (iii) the number of shares reserved for issuance pursuant to the Company’s equity incentive compensation plans. Any fraction of a share of common stock that would be created as a result of the Reverse Split will be cashed out at a price equal to the product of the closing price of the Company’s common stock on May 17, 2021 and the amount of the fractional share. The Company’s common stock will continue to trade on The Nasdaq Stock Market LLC (“Nasdaq”) under the symbol “ASRT.” The new CUSIP number for the common stock following the Reverse Split will be 04546C 205. Continental Stock Transfer & Trust, has been appointed by the Company to act as exchange agent for the Reverse Split. Stockholders owning shares via a bank, broker or other nominee will have their positions automatically adjusted to reflect the Reverse Split and will not be required to take further action in connection with the Reverse Split, subject to brokers’ particular processes. Holders of certificated shares will be contacted by the Company or its exchange agent with further details about how to surrender old certificates in exchange for new ones. About AssertioAssertio is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital, and pain and inflammation. Assertio has grown through business development including licensing, mergers, and acquisitions. Investor Contact Max NemmersHead, Investor Relations and Administrationinvestor@assertiotx.com
Downing Strategic Micro-Cap Investment Trust Plc LEI Code: 213800QMYPUW4POFFX69 Net Asset Values The Company announces the following, all of which is unaudited: Total Assets - including current period revenue* at 14 May 2021£45.96mNet Assets - including current period revenue* at 14 May 2021£45.96mNumber of shares in issue (excluding treasury):51,978,201 The Net Asset Value (NAV) per share at 14 May 2021 was: Per Ordinary share (bid price) - including current period revenue*88.41pPer Ordinary share (bid price) - excluding current period revenue*87.19p Ordinary share price 77.00pPremium/(Discount) to NAV (including current period revenue)(12.91%) * Current period revenue covers the period 01/03/2020 to 14/05/2021 and includes undistributed revenue in respect of that period.
IoT Sensors Market Research Report by Sensor Type (Accelerometer, Acoustic Sensor, Co2 Sensor, Flow Sensor, and Gyroscope), by Network Technology (Wired and Wireless), by Vertical - Global Forecast to 2025 - Cumulative Impact of COVID-19New York, May 17, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "IoT Sensors Market Research Report by Sensor Type, by Network Technology, by Vertical - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06073667/?utm_source=GNW Market Statistics:The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.1. The Global IoT Sensors Market is expected to grow from USD 7,442.59 Million in 2020 to USD 23,413.72 Million by the end of 2025.2. The Global IoT Sensors Market is expected to grow from EUR 6,525.80 Million in 2020 to EUR 20,529.59 Million by the end of 2025.3. The Global IoT Sensors Market is expected to grow from GBP 5,801.45 Million in 2020 to GBP 18,250.85 Million by the end of 2025.4. The Global IoT Sensors Market is expected to grow from JPY 794,312.94 Million in 2020 to JPY 2,498,837.22 Million by the end of 2025.5. The Global IoT Sensors Market is expected to grow from AUD 10,807.63 Million in 2020 to AUD 33,999.83 Million by the end of 2025.Market Segmentation & Coverage:This research report categorizes the IoT Sensors to forecast the revenues and analyze the trends in each of the following sub-markets:Based on Sensor Type, the IoT Sensors Market studied across Accelerometer, Acoustic Sensor, Co2 Sensor, Flow Sensor, Gyroscope, Humidity Sensor, Image Sensor, Inertial Sensor, Magnetometer, Motion Sensor, Occupancy Sensor, Pressure Sensor, Proximity Sensor, Temperature Sensor, and Touch Sensor. Based on Network Technology, the IoT Sensors Market studied across Wired and Wireless. The Wired further studied across Digital Addressable Lighting Interface, Ethernet, Knx, Lonworks, and Modbus. The Wireless further studied across Bluetooth, Nfc, Rfid, Wi-Fi, Z-Wave, and Zigbee. Based on Vertical, the IoT Sensors Market studied across Commercial IoT, Consumer IoT, and Industrial IoT. Based on Geography, the IoT Sensors Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global IoT Sensors Market including ABB, AMS AG, Analog Devices, Bosch Sensortec, Broadcom (Avago), Emerson Electric, Figaro Engineering Inc., Honeywell, Infineon Technologies, Knowles Electronics, Monnit, Murata Manufacturing, NXP Semiconductors, Omron, Safran Colibrys SA, Sensata Technologies, Sensirion, Siemens AG, Smartthings, Stmicroelectronics, TDK (Invensense), TE Connectivity, Teledyne Technologies Incorporated, and Texas Instruments. Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates and categorizes the vendors in the IoT Sensors Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.Competitive Strategic Window:The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developmentsThe report answers questions such as:1. What is the market size and forecast of the Global IoT Sensors Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global IoT Sensors Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global IoT Sensors Market?4. What is the competitive strategic window for opportunities in the Global IoT Sensors Market?5. What are the technology trends and regulatory frameworks in the Global IoT Sensors Market?6. What are the modes and strategic moves considered suitable for entering the Global IoT Sensors Market?Read the full report: https://www.reportlinker.com/p06073667/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
Police are appealing for information after a man was seriously injured in a stabbing in Tooting. The victim is currently in critical condition and his next of kin has been informed. Officers carried out enquiries and discovered the victim had been assaulted ten minutes earlier at a restaurant in Upper Tooting Road, SW17.
Announced strategic $125 million non-dilutive financing for tavapadon Welcomed Abraham Ceesay as President Appointed Scott Akamine as Chief Legal Officer Phase 1b trial for CVL-231 in schizophrenia on track for data mid-year 2021 Phase 1 acute anxiety data for darigabat now expected in the fourth quarter of 2021 Conference call and webcast scheduled for today at 8:00 a.m. EDT CAMBRIDGE, Mass., May 17, 2021 (GLOBE NEWSWIRE) -- Cerevel Therapeutics, (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today reported financial results for the quarter ended March 31, 2021 and provided key pipeline and business highlights. “Cerevel has made great progress in our quest to become the premier neuroscience company. We completed a $125 million non-dilutive financing to fund tavapadon, our most advanced asset, added key talent to our executive team, and advanced our extensive clinical and pre-clinical pipeline,” said Tony Coles, M.D., chairperson and chief executive officer of Cerevel Therapeutics. “As we continue execution of our ongoing clinical trials, we are also building the additional capabilities needed for our long-term success. We look forward to key data readouts from two of our near-term trials.” Pipeline Highlights Leveraging its deep understanding of neurocircuitry and receptor subtype selectivity, Cerevel continues to execute on its broad pipeline of novel neuroscience drug candidates. CVL-231: Cerevel’s CVL-231 is an M4-selective positive allosteric modulator (PAM) currently in a Phase 1b trial in schizophrenia. Cerevel presented data from the Phase 1 single ascending dose trial of CVL-231 in healthy volunteers at the Schizophrenia International Research Society (SIRS) Conference on April 18.Cerevel’s ongoing Phase 1b trial for CVL-231 includes a placebo-controlled pharmacodynamic assessment of change in the Positive and Negative Syndrome Scale (PANSS) total score.Data from this trial are expected mid-year 2021. Darigabat (formerly CVL-865): Cerevel’s darigabat is an α2/3/5-selective GABAA receptor PAM currently under development for anxiety and epilepsy. Cerevel is conducting a Phase 1 proof-of-principle trial in acute anxiety using a well-established CO2 inhalation challenge model in healthy volunteers.Data for the acute anxiety trial are expected in the fourth quarter of 2021. Cerevel is also conducting the REALIZE trial, a Phase 2 proof-of-concept trial in focal epilepsy. This trial remains ongoing and multiple patients have completed the 8-week maintenance portion of the trial and have opted to participate in the accompanying open-label extension trial (REALIZE OLE).Data from the REALIZE trial are expected in the second half of 2022. Tavapadon: Cerevel’s tavapadon is a D1/D5 partial agonist currently in Phase 3 trials for the treatment of Parkinson’s disease. In April 2021, Cerevel announced a $125 million non-dilutive financing that will fully fund the tavapadon Phase 3 program through New Drug Application (NDA) submission.All three of Cerevel’s Phase 3 trials in early- and late-stage Parkinson’s disease (TEMPO-1, -2, and -3) are ongoing. Cerevel has also begun dosing rollover and de novo patients in the corresponding open-label extension trial, known as TEMPO-4.Data readouts from the Phase 3 program are expected beginning in the first half of 2023. CVL-871: Cerevel’s CVL-871 is a D1/D5 partial agonist in development for treatment of dementia-related apathy. Cerevel submitted an Investigational New Drug (IND) application for CVL-871 in the first quarter of 2021.Cerevel plans to initiate screening in a Phase 2a exploratory trial in dementia-related apathy in the next few weeks and data are anticipated in the second half of 2022. CVL-936: Cerevel’s CVL-936 is a D3-preferring dopamine D3/D2 antagonist in development for substance use disorder. In April 2021, Cerevel received a notice of award for cooperative grant funding from the National Institute on Drug Abuse (NIDA) to support the development of this compound in opioid use disorder.Cerevel intends to initiate a multiple dose pre-clinical toxicology study before additional Phase 1 single and multiple ascending dose evaluations. Pre-clinical Programs: In addition to its five clinical-stage programs, Cerevel has an active drug discovery effort and a number of pre-clinical programs. Cerevel’s CVL-354 is a Kappa Opioid Receptor Antagonist (KORA) being evaluated as a potential therapy for major depressive disorder (MDD) and substance use disorder.Cerevel plans to submit an IND for CVL-354 in the second quarter of 2021.Cerevel’s CVL-047 is a selective PDE4 inhibitor that spares the PDE4D subtype, which is believed to contribute to the gastrointestinal side effects that have historically hindered development of PDE4 inhibitors in neuroscience indications.Cerevel anticipates submitting an IND for CVL-047 by the end of 2021, with plans to develop in MDD and schizophrenia. Financial Results for the First Quarter 2021 Cash Position: Cash and cash equivalents as of March 31, 2021 were $343.3 million, compared to $47.5 million as of March 31, 2020. This cash position does not include the recently announced $125 million non-dilutive tavapadon financing. This financing provides Cerevel with the flexibility to allocate capital to earlier stage assets and is expected to extend Cerevel’s cash runway into 2024.R&D Expenses: Research and development expenses for the first quarter ended March 31, 2021 were $36.6 million compared to $27.0 million for the prior year period. Total research and development expenses include equity-based compensation expense of $1.8 million and $0.9 million for the three months ended March 31, 2021 and 2020, respectively. The increase in R&D expenses is primarily attributable to continued execution of Cerevel’s late-stage and early-stage trials and increased infrastructure costs to support continued growth and advancement of the pipeline.G&A Expenses: General and administrative expenses for the first quarter ended March 31, 2021 were $14.0 million compared to $10.7 million for the prior year period. Total general and administrative expenses include equity-based compensation expense of $4.3 million and $2.1 million for the three months ended March 31, 2021 and 2020, respectively. The increase was driven primarily by one-time non-cash expenses associated with stock option compensation and general and administrative infrastructure to support the growth of the company. Conference Call InformationCerevel will host a conference call and webcast today, May 17, at 8:00 a.m. EDT to discuss its first quarter 2021 financial results and pipeline updates. To access the call, please dial 833-665-0655 (domestic) or 702-495-1044 (international) and refer to conference ID 4926779. The live webcast and accompanying slides can be accessed on the investor relations section of the Cerevel Therapeutics website here. A replay will be available in the same section of the company’s website for approximately 90 days. About Cerevel TherapeuticsCerevel Therapeutics is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. The company is tackling diseases with a targeted approach to neuroscience that combines expertise in neurocircuitry with a focus on receptor selectivity. Cerevel Therapeutics has a diversified pipeline comprising five clinical-stage investigational therapies and several pre-clinical compounds with the potential to treat a range of neuroscience diseases, including Parkinson’s, epilepsy, schizophrenia, and substance use disorder. Headquartered in Cambridge, Mass., Cerevel Therapeutics is advancing its current research and development programs while exploring new modalities through internal research efforts, external collaborations, or potential acquisitions. For more information, visit www.cerevel.com. Special Note Regarding Forward-Looking StatementsThis press release contains forward-looking statements that are based on management’s beliefs and assumptions and on information currently available to management. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by these forward-looking statements. Although we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain. Forward-looking statements in this press release include, but are not limited to, statements about the potential attributes and benefits of our product candidates, the format and timing of our product development activities and clinical trials, including the design of clinical trials and preclinical studies and the timing of initiation, completion and data readouts for clinical trials, the timing and outcome of IND submissions and other regulatory interactions, the amount and timing of payments we may receive pursuant to the tavapadon financing transaction, the sufficiency of our financial resources, including to fund the tavapadon Phase 3 development program through NDA submission and to allocate capital to earlier stage assets, and our cash runway. We cannot assure you that the forward-looking statements in this press release will prove to be accurate. Furthermore, if the forward-looking statements prove to be inaccurate, the inaccuracy may be material. Actual performance and results may differ materially from those projected or suggested in the forward-looking statements due to various risks and uncertainties, including, among others: that we may not realize the expected benefits of the financing transaction; clinical trial results may not be favorable; uncertainties inherent in the product development process (including with respect to the timing of results and whether such results will be predictive of future results); the impact of COVID-19 on the timing, progress and results of ongoing or planned clinical trials; other impacts of COVID-19, including operational disruptions or delays or to our ability to raise additional capital; whether and when, if at all, our product candidates will receive approval from the FDA or other regulatory authorities, and for which, if any, indications; competition from other biotechnology companies; uncertainties regarding intellectual property protection; and other risks identified in our SEC filings, including those under the heading “Risk Factors” in our Annual Report on Form 10-K filed with the SEC on March 24, 2021 and our subsequent SEC filings. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. The forward-looking statements in this press release represent our views as of the date of this press release. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this press release. Media Contact: Kate Contreras W2O/Real Chemistry email@example.com Investor Contact: Matthew Calistri Cerevel Therapeutics firstname.lastname@example.org TABLE 1 CEREVEL THERAPEUTICS HOLDINGS, INC.CONSOLIDATED STATEMENTS OF OPERATIONS(unaudited, in thousands, except share amounts and per share amounts) For the Three Months Ended March 31, 2021 2020 Operating expenses: Research and development$36,561 $26,959 General and administrative 14,010 10,743 Total operating expenses 50,571 37,702 Loss from operations (50,571) (37,702)Interest income, net 15 204 Other income (expense), net (425) (15,710)Loss before income taxes (50,981) (53,208)Income tax (provision) benefit, net - - Net loss and comprehensive loss$(50,981) $(53,208)Net loss per share, basic and diluted$(0.40) $(0.87)Weighted-average shares used in calculating net loss per share, basic and diluted 127,225,535 60,944,732 TABLE 2 CEREVEL THERAPEUTICS HOLDINGS, INC.CONDENSED CONSOLIDATED BALANCE SHEETS(unaudited, in thousands) As of March 31, As of December 31, 2021 2020ASSETS Current assets: Cash and cash equivalents $343,287 $383,623Prepaid expenses and other current assets 6,524 6,937Total current assets 349,811 390,560Property and equipment, net 27,597 24,165Operating lease assets 24,187 24,459Restricted cash 4,200 4,200Other long-term assets 2,309 1,889TOTAL ASSETS $408,104 $445,273 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable $7,755 $4,993Accrued expenses and other current liabilities 24,257 22,519Operating lease liabilities, current portion 2,139 2,036Total current liabilities 34,151 29,548Operating lease liabilities, net of current portion 32,952 30,969Other long-term liabilities 965 236Stockholders' equity 340,036 384,520TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $408,104 $445,273 TABLE 3 CEREVEL THERAPEUTICS HOLDINGS, INC.CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(unaudited, in thousands) For the Three Months Ended March 31, 2021 2020 Net cash flows used in operating activities $(36,418) $(29,454)Net cash flows used in investing activities (4,660) (2,556)Net cash flows provided by financing activities 742 - Net decrease in cash, cash equivalents and restricted cash (40,336) (32,010)Cash, cash equivalents and restricted cash, beginning of the period 387,823 83,682 Cash, cash equivalents and restricted cash, end of the period $347,487 $51,672 Note: Cash, cash equivalents and restricted cash balances include restricted cash of $4.2 million and $4.1 million as of March 31, 2021 and March 31, 2020, respectively.
OTTAWA and TORONTO, May 17, 2021 (GLOBE NEWSWIRE) -- HEXO Corp. ("HEXO") (TSX: HEXO; NYSE: HEXO) and 48North Cannabis Corp ("48North") (TSX-V: NRTH) are pleased to announce that they have entered into a definitive arrangement agreement (the "Arrangement Agreement") under which HEXO will acquire, by way of court-approved plan of arrangement under the Canada Business Corporations Act, all of 48North’s issued and outstanding common shares in an all-share transaction valued at approximately $50 million on an enterprise value basis (the "Transaction"). “As we continue down our path towards achieving a top two position in Canada by adult-use sales, we are looking forward to welcoming the 48North team into the HEXO family.” said Sebastien St-Louis, CEO and co-founder of HEXO Corp. “48North’s innovative product portfolio complements HEXO’s existing brands which, combined with their additional market penetration, will further strengthen HEXO’s position in the Canadian market. We expect the deal could offer up to $12 million worth of accretive synergies within one year following the close and ideally position HEXO to continue executing on our domestic and international growth strategy.” “48North has always been a brand-led, consumer-centric licensed cannabis producer with a mission to provide an expansive portfolio of high-quality, accessibly-priced products across the country," said Charles Vennat, CEO of 48North. “Like HEXO, 48North believes that the combination should deliver meaningful synergies, a stronger financial position with increased flexibility, and should position the combined company to meet growing consumer demand on a national basis. I believe this Transaction is beneficial to our shareholders, customers, partners, and other stakeholders. We look forward to working closely with HEXO to complete this transaction," added Charles Vennat, CEO of 48North. Transaction Highlights Strengthens HEXO’s position as a leader in the Canadian adult-use (recreational) market: Assuming completion of the Transaction and the previously announced transaction with Zenabis Global Inc., expected to close on June 1, 2021, the combined organization would be among the leading licensed producers in terms of combined Canadian recreational sales, based on their most recent financial statements and results.Diversifies product portfolio: The addition of 48North’s innovative product offering, including topicals, bath and intimacy products provides a strong base for potential future CPG partnerships in the US, Canada and internationally.Offers accretive synergies: HEXO estimates that, assuming completion of the Transaction, it may realize annual synergies of up to $12 million within one year of close, through cost of goods reductions, additional capacity utilization in HEXO’s Belleville Centre of Excellence and selling, general and administrative savings, which, if realized, should allow HEXO to continue its path towards positive earnings.Provides 48North shareholders access to participate in HEXO’s future: The 48North shareholders will receive HEXO common shares following close of the Transaction along with access to HEXO’s expertise in manufacturing, operational excellence and the Powered by HEXO® solution. 48North shareholders will also benefit from HEXO’s wide adult-use distribution networks and future growth in Canada, the US and internationally. Under the terms of the Arrangement Agreement, 48North shareholders will receive 0.02366 of a HEXO common share in exchange for each 48North common share held (the “Exchange Ratio”). Taking into account half of the working capital bridge loan being made available to 48North by HEXO as part of the Transaction and as described in greater detail below, the Exchange Ratio implies a premium per 48North common share of approximately 20% based on the 10-day volume-weighted average price ("VWAP") of 48North common shares on the TSX-V and HEXO common shares on the TSX as of the close of markets on May 14, 2021. It is anticipated that 48North’s outstanding common share purchase warrants will, assuming and following closing of the Transaction, remain warrants issued by 48North but will be adjusted in accordance with their terms to ultimately become exercisable to receive common shares of HEXO based on the Exchange Ratio. HEXO has entered into voting and support agreements with 48North’s directors and officers with respect to all 48North shares owned by them as well as voting and support agreements with certain other shareholders covering all of those shareholders’ common shares of 48North. As a result, in total approximately 25.9% of 48North’s issued and outstanding common shares are subject to signed voting and support agreements with commitments to support and vote in favour of the Transaction. The Transaction has been unanimously approved by HEXO’s board of directors. 48North’s board of directors also unanimously approved the Transaction after receiving the unanimous recommendation of a special committee of independent directors (the “Special Committee”). 48North’s board of directors unanimously recommends that its shareholders vote in favour of the Transaction. Additional Transaction Details The Transaction requires approval by at least 66 2/3% of the votes cast by the shareholders of 48North present at a special meeting of 48North shareholders, in addition to a separate simple majority approval requirement excluding the votes cast by the Chief Executive Officer of 48North holding certain incentive securities, the vesting of which will be accelerated in connection with the Transaction. The Transaction does not require HEXO shareholder approval. The Arrangement Agreement includes customary provisions, including non-solicitation provisions, subject to the right of 48North to accept a superior proposal in certain circumstances, with HEXO having a period of five business days to exercise a right to match any such superior proposal for 48North. The Arrangement Agreement also provides for a termination fee of $2.0 million payable by 48North to HEXO if the Transaction is terminated in certain specified circumstances, as well as reciprocal expense reimbursement provisions if the Transaction is terminated by either party in certain other specified circumstances. In addition to the approval by 48North’s shareholders, the Transaction is subject to the receipt of certain regulatory, court and stock exchange approvals and the satisfaction of customary conditions precedent in transactions of this nature, as well as certain other specified conditions precedent set out in the Arrangement Agreement. Upon completion of the Transaction, existing HEXO and 48North shareholders would, based on the number of each company’s issued and outstanding common shares as at May 14, 2021, respectively own approximately 96% and 4% of HEXO on a pro forma non-diluted basis. The Transaction also contemplates HEXO providing 48North with a $5 million subordinated secured bridge loan with a 6-month term within 30 days following signing of the Arrangement Agreement to fund 48North’s short term working capital requirements. Further information regarding the Transaction, will be included in the information circular that 48North will prepare, file, and mail in due course to its shareholders in connection with its special meeting to be held to consider the Transaction. 48North will be applying in the coming weeks to the Superior Court of Justice of Ontario to obtain an interim order approving various procedural and related matters in order to convene the special meeting of shareholders in connection with the Transaction. The Arrangement Agreement will be filed under the SEDAR profiles of 48North and HEXO on the SEDAR website at www.sedar.com. None of the securities to be issued pursuant to the Arrangement Agreement have been or will be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities laws, and any securities issued upon closing of the Arrangement are anticipated to be issued in reliance upon the exemption from such registration requirements provided by Section 3(a)(10) of the U.S. Securities Act and applicable exemptions under state securities laws. This news release does not constitute an offer to sell or the solicitation of an offer to buy any securities. Recommendation of 48North’s Board The Transaction has been unanimously recommended to the 48North board of directors by the Special Committee, comprised of William Assini, Anne Darche and James Gervais. After receiving the recommendation of the Special Committee as well as independent financial and legal advice, 48North’s board of directors has unanimously determined that the Transaction is in the best interests of 48North and its securityholders, and the board of directors unanimously recommends that 48North’s shareholders vote in favour of the Transaction. The board of directors of 48North has obtained a fairness opinion from Echelon Wealth Partners Inc. to the effect that, as of the date of the Arrangement Agreement, and subject to the assumptions, limitations, and qualifications on which such opinion is based, the consideration to be received pursuant to the Transaction is fair, from a financial point of view, to 48North’s shareholders. Advisors and Counsel Norton Rose Fulbright Canada LLP is acting as legal counsel to HEXO. Cormark Securities Inc. is acting as financial advisor to 48North in connection with the Transaction. Bennett Jones LLP is acting as legal counsel to 48North. About HEXO Corp HEXO Corp is an award-winning consumer packaged goods cannabis company that creates and distributes innovative products to serve the global cannabis market. The Company serves the Canadian adult-use markets under its HEXO Cannabis, Up Cannabis and Original Stash brands, and the medical market under HEXO medical cannabis. For more information please visit hexocorp.com About 48North Cannabis Corp. 48North Cannabis Corp. (TSXV:NRTH) is a brand-led, consumer-centric licensed cannabis producer with an expansive portfolio of high-quality, accessibly priced products available across the country. The company serves the Canadian medical and adult-use markets with its brand portfolio that includes: 48North, an innovative and high-quality cannabis brand focused on thoughtfully crafted everyday staples for passionate cannabis users; Trail Mix, an accessibly priced brand formulated with taste and aroma-first flavour profiles; Latitude, a next-generation lifestyle platform and premium, natural cannabis collection focused on wellness, beauty, and beyond. 48North operates two indoor-licensed cannabis production sites in Ontario and cultivates unique genetics at its wholly owned subsidiary, DelShen Therapeutics Corp., and processes cannabis and manufactures next generation cannabis products at Good & Green Corp., both licensed producers under the Cannabis Act. CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact are forward-looking statements. Forward looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "potential", "believe", "intend", “estimate” or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to: statements with respect to the completion of the Transaction and the timing for its completion; the satisfaction of closing conditions which include, without limitation (i) required 48North shareholder approval, (ii) necessary court approval in connection with the plan of arrangement, (iii) receipt of any required approvals under the Competition Act, (iv) certain termination rights available to the parties under the Arrangement Agreement, (v) HEXO obtaining the necessary approvals from the TSX and the NYSE for the listing of its common shares in connection with the Transaction (vi) 48North receiving approval for the delisting of its shares on the TSX-V, and (vii) other closing conditions, including compliance by HEXO and 48North with various covenants contained in the Arrangement Agreement; statements with respect to the effect of the Transaction on HEXO and its strategy going forward and statements with respect to the anticipated benefits associated with the acquisition of 48North. Forward-looking statements are based on certain assumptions regarding HEXO and 48North, including the completion of the Transaction, anticipated benefits from the Transaction, and expected growth, results of operations, performance, industry trends and growth opportunities. While HEXO and 48North consider these assumptions to be reasonable, based on information currently available, they may prove to be incorrect. Readers are cautioned not to place undue reliance on forward-looking statements. The assumptions of HEXO and 48North, although considered reasonable by them at the time of preparation, may prove to be incorrect. In addition, forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; future legislative, tax and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the ability of HEXO to implement its business strategies; competition; currency and interest rate fluctuations and other risks. Among other things, there can be no assurance that the Transaction will be completed or that the anticipated benefits from the Transaction will be achieved. Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. For more information on the risk, uncertainties and assumptions that could cause anticipated opportunities and actual results to differ materially, please refer to the public filings of HEXO and 48North which are available on SEDAR at www.sedar.com, including the “Risk Factors” section in HEXO’s Annual Information Form dated October 29, 2020, 48North’s Annual Information Form dated March 1, 2021 and the most recent management’s discussion and analysis filed by each of HEXO and 48North. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect our expectations as of the date hereof, and thus are subject to change thereafter. HEXO and 48North disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Notice to U.S. Holders. Both HEXO and 48North have been formed outside of the United States. The Transaction will be subject to disclosure requirements of Canada that are different from those of the United States. Financial statements included in the documents, if any, will be prepared in accordance with Canadian accounting standards and may not be comparable to the financial statements of United States companies. It may be difficult for a securityholder in the United States to enforce his/her/its rights and any claim a securityholder may have arising under U.S. federal securities laws, since the companies are located in Canada, and some or all of their officers or directors may be residents of Canada or another country outside of the United States. A securityholder may not be able to sue a Canadian company or its officers or directors in a court in Canada or elsewhere outside of the United States for violations of U.S. securities laws. It may be difficult to compel a Canadian company and its affiliates to subject themselves to a U.S. court's judgment. Neither the TSX,nor NYSE accepts responsibility for the adequacy or accuracy of this release. For further information, please contact: HEXO Investor Relations:invest@HEXO.comwww.hexocorp.com Media Relations:(819) email@example.com 48North Media Relations Email: firstname.lastname@example.org Investor Relations E-mail: email@example.com
The Global Test and Measurement Equipment Market has been estimated to reach USD 28.6 billion in 2021 and is projected to grow at a CAGR of 4.0% during the forecast period till 2030.Pune, May 17, 2021 (GLOBE NEWSWIRE) -- The Global Test and Measurement Equipment Market Size has been estimated to reach USD 28.6 billion in 2021 and is projected to grow at a CAGR of 4.0% during the forecast period till 2030. The test and measurement equipment refers to a device used to stimulate actual inputs to a system under test. They assist the designer to test the real life condition simulations. Various equipment used in a wide variety of applications are electronic test equipment, material testing equipment, laboratory test equipment, measuring microscope, particle analysis, and others. Get Sample Copy of This Report @ https://www.quincemarketinsights.com/request-sample-68982 The following factors are considered while choosing right measurement equipment - cost & portability, type of material being tested, and which properties need to be measured. For instance, to measure mechanical properties of manufactured products, the key characteristics tested are hardness, friction, fatigue, compression, impact, and others. To configure automated test and measurement systems several modular instrumentation platforms are used to do quality assurance check, inspect, and production testing of devices. For instance, in the automotive sector, test equipment help to improve functionality and operability of vehicles and its parts. Additionally, safety compliance testing is important for checking the performance of products in the market. Over the forecast period, rising demand for accurate & efficient devices, high performance, and good shelf life will boost the market for test and measurement equipment. Testing helps in identifying timely degradation of components due to external disturbances like vibrations, heat, shock, and other environmental factors. However, the high price of test and measurements equipment and unwanted errors can be barriers in the growth of the test and measurement equipment market. The growing advanced and integrated technologies like 5G, big data , LTE & 802.11 Wifi standard, IoT, RF testing, high speed digital standards, software models, power applications, environmental testers in major industries like automobile, aerospace, medical equipment, electronics, and semiconductor will open up new opportunities in the test and measurement equipment market. Some Significant Market Developments Considered in the Report: Rohde & Schwarz has developed the 5G NonStandalone network in its factories in Germany in April 2021. The network is at the early stage of integration, and the aim of this private 5G network is to optimize the production processes and validate its own network testing solutions.In April 2021, Yokogawa Test & Measurement Corporation has announced the development of its current sensor element (760903) to use with power measurement solution, precision power analyzer (WT5000).Fluke Corporation, in April 2021, has introduced the new clamp meters, which minimize the risk of electric shock and are the only clamps without test leads that accurately make non-contact voltage measurements. COVID-19 Impact on the Global Test and Measurement Equipment Market The QMI team is closely monitoring the impact of COVID-19 on the global test and measurement equipment industry, and it has been observed by our team that the demand for test and measurement equipment is slowing down during the pandemic time. But it is anticipated to grow with a healthy rate from mid-2021. To control the spread of the pandemic, many countries across the globe have put a strict lockdown norm, which is hampering all kinds of business activities. Enquiry Before Buying This Report @ https://www.quincemarketinsights.com/enquiry-before-buying/enquiry-before-buying-68982 The demand for and supply of raw materials and product manufacturing and distribution have been completely disrupted due to the closing down of the marketplace. Among various industries, transportation, aviation, automotive, and electronic industries have suffered huge financial losses. This has created weak demand for several products and components, and test and measurement equipment are one of them. All these factors have been analyzed in details in this report. Global Test and Measurement Equipment Market, By Product Based on product, the test and measurement equipment market is segmented into general purpose test equipment and mechanical test equipment. The general purpose test equipment is expected to grow significantly during the forecast period. Some common devices under general purpose testing equipment are multimeter, logic analyzer, spectrum analyzer, audio and RF signal generator, oscilloscope, and others. These equipment have a wide variety of applications in industrial & manufacturing industry, electronics & semiconductor industry, automotive, and aerospace industry. The mechanical test equipment consist of compression testers, adhesion testers, shear & tensile testers, drop & shock testers, vibration testers, and others. The growing demand for quality control & assurance in manufacturing processes will significantly contribute to the growth of mechanical test equipment over the forecast period. Global Test and Measurement Equipment Market, By Service Based on service, the market is segmented into calibration services and repair/after sales services. Calibration services segment in expected to grow significantly during the forecast period. The proper maintenance and routine calibration for test & measuring equipment are essential, as it helps the instruments perform accurately over a long period of time. The repair services will also have considerable share in the growth of test and measurement equipment market. The requirement of upgradation of equipment in timely manner, and parts replacement or adjustments will contribute to the growth of repair/after sales segment. Global Test and Measurement Equipment Market, By End-User Based on end-user, the market is segmented into aerospace & defense, automotive & transportation, electronics & semiconductor, industrial & manufacturing, healthcare, and education. The automotive segment is expected to have the largest share in the test and measurement equipment market. The rising safety regulations of the automobile industry and its environmental impact will fuel the growth of the market for test and measurement equipment. The testing and calibration of electronic devices in the aerospace and defense industry is very important and hence, will boost the growth of the market. Global Test and Measurement Equipment Market, By Region Based on region, the global test and measurement equipment market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South America. The North America region is expected to exhibit significant growth during the forecast period. The growing advanced technologies including optimization in performance of equipment, data centers, 5G technology, IoT and power management applications in electronics, automotive, and aerospace industries will fuel the market in this region. The Asia Pacific region is expected to grow due to the presence of some prominent market leaders in countries like China, South Korea, and India. Some Major Findings of the Test and Measurement Equipment Market Report Include: Major global market trend & forecasts analysis along with a country-specific market analysis for up to 25 countries.An in-depth global test and measurement equipment market analysis by the aforementioned segments, along with an analysis of trend-based insights and factors.Profiles of major market players operating in the global test and measurement equipment market, which include Anritsu Corp, Fortive, Bureau Veritas, Keysight Technologies, National Instruments, Rohde & Schwarz, Yokogawa Electric Corp, EXFO Inc, VIAVI solutions, Advantes Corp, Teledyne Technologies, Texas Instruments, Spectris PLC, IKM Instrutek, and others.Competitive benchmarking, product offering details, and growth strategies adopted by the leading market players, along with their major investments in the last five years.Key impact factor analysis across regions that includes analysis, along with the drivers, restraints, opportunities, and challenges that are prevailing in the global test and measurement equipment market.Impact of COVID-19 on the global test and measurement equipment market Browse key industry insights spread across 195 pages with 135 market data tables and 91 figures & charts from the report, “Global Test and Measurement Equipment Market by Product (General Purpose Test Equipment, Mechanical Test Equipment), Service (Calibration Services and Repair/After Sales Services), End-User (Aerospace & Defense, Automotive & Transportation, Electronics & Semiconductor, Industrial & Manufacturing, Healthcare and Education) and Region (North America, Europe, Asia Pacific, Middle East & Africa, and South America) — Market Size and Forecasting (2018–2030)” in depth analysis along with the table of contents (ToC). Buy Now Full Report: https://www.quincemarketinsights.com/insight/buy-now/global-test-and-measurement-equipment-market/single_user_license For Query: firstname.lastname@example.org or https://www.quincemarketinsights.com/contact-us/ Browse Related Reports: Mobile and Wireless Backhaul Market, By Equipment (Microwave, Millimeter Wave, Sub 6 GHZ, Test and Measurement), By Services (Network, System Integration, Professional), By Region (North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, and Rest of the World) – Market Size & Forecasting to 2028 https://www.quincemarketinsights.com/industry-analysis/mobile-and-wireless-backhaul-market Communication Test and Measurement Market, By Test Solutions (Wireless, Wireline), By Type of Test (Enterprise Test, Field Network Test, Lab and Manufacturing Test, Network Assurance Test), By Services (Product Support Service, Professional Service, Managed Service), By End-User (Network Equipment Manufacturer, Mobile Device Manufacturer, Telecommunication Service Provider, Enterprise), By Region (North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, and Rest of the World) – Market Size & Forecasting to 2028 https://www.quincemarketinsights.com/industry-analysis/communication-test-and-measurement-market Blood Flow Measurement Devices Market, By Product (Ultrasound (Transit Time Flow Meter), Laser Doppler), By Application (Invasive (CABG, Microvascular Surgery), Non-invasive (Cardiovascular, Gastroenterology & Tumor Monitoring)), By Region (North America, Eastern Europe, Western Europe, Asia Pacific, Middle East, Rest of the World) – Market Size & Forecasting (2016-2028) https://www.quincemarketinsights.com/industry-analysis/blood-flow-measurement-devices-market Predictive Maintenance Market, By Component (Service and Solution), By Organization Size (Small & Medium Enterprises and Large Enterprises), By Technique (Vibration Monitoring, Oil Analysis, Visual Inspection, Shock Pulse, Ultrasonic Leak Detectors, Electrical Insulation, Performance Testing, Wear & Dimensional Measurements, Signature Analysis, Time & Frequency Domain, Non-Destructive Testing, and Others), By Deployment Type (Cloud and On-premise), By End User (Manufacturing, Aerospace & Defense, Healthcare, Automotive, Transportation, and Government), and By Region (North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, and Rest of the World) – Market Size & Forecasting (2016-2025) https://www.quincemarketinsights.com/industry-analysis/predictive-maintenance-market Global Proximity - Displacement Sensors Market, By Type (Inductive, Photoelectric, Capacitive, Ultrasonic, Magnetic, LVDT), By Application (Parking, Ground Proximity Warning, Vibration Monitoring-Measurement, Anti-Aircraft Warfare, Roller Coasters, Conveyer System, Mobile Devices, Assembly Line Testing), By End User (Automotive, Pharmaceuticals, Food-Beverage, Pulp-Paper, Elevators-Escalators, Manufacturing, Metals-Mining Industry), By Region (North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, Rest of the World) – Market Size & Forecasting (2016-2025) https://www.quincemarketinsights.com/industry-analysis/proximity-displacement-sensors-market CONTACT: Ajay D Quince Market Insights Pune India Phone: US +1 208 405 2835 UK +44 1444 39 0986 APAC +91 706 672 4848 Email: email@example.com Web: www.quincemarketinsights.com
- Adjournment Solely to Vote on the Reverse Split and Proportional Authorized Shares Reduction Proposal (Proposal 2) and Increase in Authorized Shares Proposal (Proposal 3) - Both Leading Independent Advisory Firms have Issued Favorable Recommendations on Proposal 2 and Proposal 3 LAKE FOREST, Ill., May 17, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced partial results and the partial adjournment of the Company’s 2021 Annual Meeting of Shareholders (the “Annual Meeting”), which was held at 1:00 p.m. Central Time on May 11, 2021 and at which time all director nominees were elected and Proposals 4 and 5, as set forth in the Company’s Definitive Proxy Statement, were approved by stockholders. The Company adjourned the meeting with respect to Proposal 2 (the “Reverse Split and Proportional Authorized Shares Reduction Proposal”) and Proposal 3 (the “Increase in Authorized Shares Proposal”) for the limited purpose of allowing additional time for stockholders to vote. Support for Proposal 2 has exceeded 80% of the votes cast on the proposal, though approval of more than 50% of all of the Company’s outstanding shares of common stock is necessary for the proposal to be approved. While the votes cast prior to adjournment strongly favor Proposal 2, approximately 86 million shares remained unvoted on the proposal at the time of adjournment. The principal reason for the Reverse Split and Proportional Authorized Shares Reduction Proposal is to give the Board discretion to increase the per-share trading price of the Company’s common stock to meet the minimum bid price requirements for continued listing on Nasdaq. Support for Proposal 3 has exceeded 76% of the votes cast on the proposal. However, approval of more than 50% of all of the Company's outstanding shares of common stock is necessary for the proposal to be approved. While the votes cast prior to adjournment strongly favor Proposal 3, approximately 86 million shares remained unvoted at the time of adjournment. Both leading independent proxy advisory firms, Institutional Shareholder Services and Glass Lewis & Co., have recommended in favor of the Reverse Split and Proportional Authorized Shares Reduction Proposal and the Increase in Authorized Shares Proposal. If you have already voted your shares on Proposals 2 or 3, you do not need to vote again and we thank you for your vote. “I particularly appreciate the substantial shareholder support for the reverse split and authorized shares reduction proposal, as demonstrated by the affirmative vote of 80% of the votes cast to date on this matter,” said Dan Peisert, President and Chief Executive Officer of Assertio. “Over the next few weeks, we will be reaching out to additional shareholders through various measures to seek additional votes on the proposal.” If you have any questions or need assistance voting your shares, please call the firm assisting Assertio with the solicitation of proxies, Innisfree M&A Incorporated, toll-free at 1 888-750-5834. The adjourned 2021 Annual Meeting will be reconvened on June 9, 2021 at 1:00 p.m. (Central Time) for the sole purpose of allowing additional time for stockholders to vote on Proposals 2 and 3. The reconvened meeting will be held as a virtual (online) meeting, accessible by visiting https://www.cstproxy.com/assertiotx/2021, or by telephone (listen-only) as follows: Date:Wednesday, June 9, 2021Time1:00 p.m. Central TimeDial-in numbers:1 877-770-3647 (domestic) +1 312-780-0854 (international)Passcode:62782283# About AssertioAssertio is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital, and pain and inflammation. Assertio has grown through business development including licensing, mergers, and acquisitions. Investor Contact Max NemmersHead, Investor Relations and Administrationinvestor@assertiotx.com Additional Information and Where to Find It The Company has filed a definitive proxy statement on Schedule 14A and associated proxy card (the “Proxy Statement”) with the U.S. Securities and Exchange Commission (the “SEC”), which was filed on April 12, 2020 and amended on April 30, 2020. The Company, its directors, its executive officers and certain other individuals set forth in the definitive proxy statement will be deemed participants in the solicitation of proxies from stockholders in respect of the Annual Meeting. Information regarding the names of the Company’s directors and executive officers and certain other individuals and their respective interests in the Company by security holdings or otherwise is set forth in the Proxy Statement. BEFORE MAKING ANY VOTING DECISION, STOCKHOLDERS OF THE COMPANY ARE URGED TO READ ALL RELEVANT DOCUMENTS FILED WITH OR FURNISHED TO THE SEC, INCLUDING THE PROXY STATEMENT AND ANY SUPPLEMENTS THERETO AND ACCOMPANYING PROXY CARD. The Proxy Statement and a form of proxy have been mailed to shareholders of the Company. Investors and shareholders can obtain a copy of the documents filed by the Company with the SEC, including the Proxy Statement, free of charge by visiting the SEC’s website, www.sec.gov.
The global security-as-a-service market is estimated to reach a valuation of USD 10.4 billion in 2021 and is projected to grow at a CAGR of 17% during the forecast period till 2030.Pune, India, May 17, 2021 (GLOBE NEWSWIRE) -- The global security-as-a-service market is estimated to reach a valuation of USD 10.4 billion in 2021 and is projected to grow at a CAGR of 17% during the forecast period till 2030. Security-as-a-service (SaaS) provides cloud-hosted security services on a subscription basis. Security-as-a-service is widely used by small, medium, and large businesses because of the primary benefits it provides for corporate infrastructures, such as fulfilling the duties of in-house security teams, increasing security requirements as the business expands, and avoiding the costs and maintenance of on-premise alternatives. Security-as-a-service (SaaS) is an outsourced service in which a third party operates and manages security. The use of anti-virus software over the Internet is the simplest example of security-as-a-service. Get Sample Copy of This Report @ https://www.quincemarketinsights.com/request-sample-62404 Online business enterprises face server-related challenges when it comes to cybersecurity. They don't have any on-site hardware to monitor cybersecurity since they don't have a physical workplace. These enterprises also lack the financial resources to hire analysts and security specialists. However, since most companies operate on a network or in the cloud, the risk of cyber-attacks is increasing as sophisticated attacks and threats become more frequent. Such enterprises can use security-as-a-service to outsource their security needs to a provider. The provider will be in charge of security services, such as authentication, intrusion detection, antivirus, and malware management. Off-site security facilities can be handled using the provider's hardware and cybersecurity equipment. Without providing their resources for this task, organizations can easily monitor threats within their networks using security-as-a-service. The demand for security-as-a-service solutions has grown in response to rising threats to businesses and corporations, and an increase in identity fraud. Using IAM (Identity and Access Management) tools is one of the constructive ways to tackle identity fraud. These solutions rely on a centralized framework to determine and modify user access rights and monitor authorization based on those rights. To protect against cybersecurity threats, security service providers are constantly upgrading their software. Although it is impossible to prevent all threats, enterprises should take steps to minimize the risk, such as limiting access to confidential data and increasing the use of controlled security services. The growing dependence on third-party providers, such as managed security services, has increased the risk of planned attacks. Since they are well-informed and aware of emerging security technology and breaches, many hacker groups specialize in planned hacking for safe applications. This factor can hinder the market growth. Some Significant Market Developments Considered in the Report: In September 2020, Proofpoint, Inc., a pioneer in cybersecurity and enforcement, expanded its partnership with CyberArk, one of the global leaders in privileged access management. Because of the enhanced integration of Proofpoint Targeted Attack Protection with CyberArk's Privileged Access Security Solution, organizations can identify their very attacked people (VAPs), apply additional security policies to their high-risk users with privileged access, and remediate phishing attempts.In May 2020, McAfee, a device-to-cloud cybersecurity company, collaborated with Atlassian, a leading provider of team collaboration and productivity software. Customers of Atlassian can use McAfee MVISON Cloud to extend their security policies to their use of Atlassian services because of this collaboration.In July 2020, Thales Group collaborated with Google Cloud to improve enterprises' ability to securely transfer confidential data between public cloud, hybrid, and private IT infrastructures. COVID-19 Impact on Global Security-as-a-Service Market The QMI team is closely monitoring the impact of COVID-19 on the global security-as-a-service industry, and it has been observed by our team that the demand for security-as-a-service is slowing down during the pandemic time. However, starting in mid-2021, it is expected to grow at a sustainable rate. Many countries around the globe have imposed stringent lockdown regulations to prevent the pandemic from spreading, causing all types of business operations to be hampered. The demand and supply of raw materials and product manufacturing and distribution have been completely disrupted due to the closing down of the marketplace. Among various industries, transportation, aviation, oil and gas, and electronic industries have suffered huge financial losses. This has created weak demand for several products and components, and security-as-a-service are one of them. In this report, all of these aspects have been closely examined. Enquiry Before Buying This Report @ https://www.quincemarketinsights.com/enquiry-before-buying/enquiry-before-buying-62404 Global Security-as-a-Service Market, by Component Based on component, the global security-as-a-service market is bifurcated into solution and services. The solution segment is further divided into identity and access management, data loss prevention (DLP), continuous monitoring, intrusion management, business continuity and disaster recovery, security information and event management, vulnerability scanning, email security, network security, web security, and others. The service segment is further divided into training and education, consulting, and support and maintenance. The security information and event management (SIEM) segment is growing as it combines the functions of security information management and security event management into one system. Security-as-a-service providers use SIEM to collect and compile security logging data from all devices in the security management domain. End systems, servers, local and cloud applications, switches, routers, firewalls, and anti-virus software are some of the products in this category. SIEM re-arrange and analyze possible security incidents and generate a report, and alerts the security-as-a-service provider. Global Security-as-a-Service Market, by Organization Size Based on the organization size, this market is bifurcated into small and medium-sized enterprises (SMEs) and large enterprises. The small and medium-sized enterprises (SMEs) segment is expected to grow significantly during the forecast period. SME's (small and medium-sized enterprises) are a major source of innovation and growth around the world. Since setting up and running a whole server system in a traditional way is challenging and costly, SMEs stand to benefit the most from cloud computing. Small and medium-sized enterprises (SMEs) are increasingly adopting security-as-a-service technologies as they have minimal resources to manage software applications and other business operations. Furthermore, cloud-based systems are commonly used by small businesses. Cloud-based systems, on the other hand, are often vulnerable to cyber-attacks due to a lack of authentication. Therefore, security-as-a-service plays an important role in securing their business, fueling demand and propelling market growth. Global Security-as-a-service Market, by Vertical Based on vertical, this market is classified into banking, financial services, and insurance (BFSI), energy and utilities, government and defense, healthcare, IT and telecom, manufacturing, retail, and others. As this banking, financial services, and insurance (BFSI) industry contribute to the economy, it remains a national priority and a concern for people's well-being. Therefore, significant security steps are taken to safeguard this industry against sophisticated attacks and threats. This factor is expected to fuel the demand for a security-as-a-service model in the BFSI industry. Global Security-as-a-service Market, by Region Based on regions, the global security-as-a-service market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The North America region is projected to hold a significant market share over the forecast period. This growth is attributed to the presence of a large number of security-as-a-service vendors in the region. The U.S. accounts for the largest market share in the North American region, owing to the presence of major market players in the country. Increased development of unprotected new technologies, such as the Internet of Things (IoT), and a rise in cybercrime activity in North America have resulted in a rise in malicious attacks. Therefore, in North America the security-as-a-service model is rapidly adopted by enterprises, thereby boosting the market growth. Some Major Findings of the Security-as-a-service Market Report Include: Major global market trend and forecasts analysis along with the country-specific market analysis for up to 25 countriesAn in-depth global security-as-a-service market analysis by the aforementioned segments, along with an analysis of trend-based insights and factorsProfiles of major market players operating in the global security-as-a-service market, which include Broadcom Inc., Trend Micro Incorporated, McAfee, LLC, Fortinet, Inc., Panda Security, S.L., CipherCloud, Inc., Zscaler, Inc., Alert Logic, Inc, Radware Ltd., Happiest Minds, Paladion's, Forcepoint, Digital Guardian, Volta, Okta, Proofpoint Inc., and Thales GroupCompetitive benchmarking, product offering details, and growth strategies adopted by the leading market players, along with their major investments in the last five yearsKey impact factor analysis across regions that includes analysis, along with the drivers, restraints, opportunities, and challenges that are prevailing in the global security-as-a-service market.Impact of COVID-19 on the global security-as-a-service market Browse key industry insights spread across 191 pages with 134 market data tables and 89 figures & charts from the report, “Security-as-a-service Market” in depth analysis along with the table of contents (ToC). Buy Now Full Report: https://www.quincemarketinsights.com/insight/buy-now/security-as-a-service-market/single_user_license Browse Related Reports: Data Loss Prevention Market, By Solution Type (Network DLP, Storage DLP, Endpoint DLP), By Deployment Type (On-Premise, Cloud), By Applications (Encryption, Centralized Management, Policy, Standards & Procedures, Web & Email Protection, Cloud Storage, Incident Response & Workflow Management), By Service (Consulting, System Integration & Installation, Managed Security Services (MSS), Education & Training, Risk & Threat Assessment), By Organization Size (Small & Medium-Sized Businesses (SMBS), Large Enterprises), By Vertical (Aerospace, Defense& Intelligence, Government (Excluding Defense) and Public Utilities, Banking, Financial Services and Insurance (BFSI), Telecomm and IT, Healthcare, Retail & Logistics, Manufacturing), By Region (North America, Europe, Asia Pacific, Middle East & Africa, and South America) – Market Size & Forecasting To 2028. https://www.quincemarketinsights.com/industry-analysis/data-loss-prevention-market Wireless Network Security Market, By Solutions (Firewall, IPS/IDS, Encryption, I&AM, UTM), By Services (Security Operations, Consulting, Managed Security Services), By End User (Large Enterprises, Small & Medium Enterprises (SMEs)), By Vertical (Banking, Financial Services, and Insurance (BFSI), Government & Utilities, Telecommunication and Information Technology, Healthcare, Aerospace & Defense, Retail, Manufacturing), By Region (North America, Europe, Asia Pacific, Middle East & Africa, and South America) – Market Size & Forecasting To 2028. https://www.quincemarketinsights.com/industry-analysis/wireless-network-security-market Utilities Security Market, By Solution (Physical Security, Cyber Security), By End User (Oil & Gas, Electricity, Others), By Region (North America, Asia Pacific, Europe, Middle East & Africa, and South America) – Market Size & Forecasting To 2028. https://www.quincemarketinsights.com/industry-analysis/utilities-security-market Machine Learning as a Service (MLaaS) Market, By Type (Special Services and Management Services), By Organization Size (SMEs and Large Enterprises), By Application (Marketing & Advertising, Fraud Detection & Risk Analytics, Predictive Maintenance, Augmented Reality, Network Analytics, and Automated Traffic Management), By End User (BFSI, IT & Telecom, Automobile, Healthcare, Defense, Retail, Media & Entertainment, and Communication), and By Region (North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, and Rest of the World) – Market Size & Forecasting (2016-2025) https://www.quincemarketinsights.com/industry-analysis/machine-learning-as-a-service-mlaas-market Global Data Warehouse as a Service (DWaaS) Market, By Usage (Data mining, Reporting, Analytics), By Deployment mode (Private cloud, Public cloud, Hybrid cloud), By Application (Fraud detection and threat management, Supply chain management, Asset management, Risk and compliance management, Customer analytics, Others), By Vertical (BFSI, Retail & e-commerce, Telecommunication and IT, Healthcare and life sciences, Manufacturing and automotive, Government and public sector, Travel and hospitality, Media and entertainment, Others), By Region (North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, Rest of the World) – Market Size & Forecasting(2016-2025) https://www.quincemarketinsights.com/industry-analysis/data-warehouse-as-a-service-dwaas-market For Query: firstname.lastname@example.org or https://www.quincemarketinsights.com/contact-us/ CONTACT: Ajay D Quince Market Insights Pune India Phone: US +1 208 405 2835 UK +44 1444 39 0986 APAC +91 706 672 4848 Email: email@example.com Web: www.quincemarketinsights.com
Stem, Inc. (NYSE:STEM) announces financial results for the first quarter ended March 31, 2021.
VANCOUVER, British Columbia, May 17, 2021 (GLOBE NEWSWIRE) -- Nanotech Security Corp. (TSXV: NTS) (OTCQX: NTSFF) (“Nanotech” or the “Company”), a leader in the development of secure and visually memorable nano-optic security features used in the government and banknote and brand protection markets, announces a $635,000 purchase order for LumaChrome™ colour-shifting film to be delivered this summer. Nanotech is supplying its LumaChrome colour-shifting film to a partner for conversion into a security thread for a banknote application. This order marks over 20 consecutive years that the Company has delivered its LumaChrome film for security threads with this particular partner. “Nanotech is one of the few suppliers in the world capable of producing such high-security colour-shifting films. We are honored to be the trusted supplier for this central bank,” said President and CEO Troy Bullock. “This order will be produced in our secure production facility in Thurso, Quebec.” Nanotech specializes in designing, originating, recombining, and mass-producing anti-counterfeit films like LumaChrome. This anti-counterfeiting film is extremely durable, experiences virtually no degradation over the lifetime of the substrate and is readily converted into multiple application formats. Nanotech’s LumaChrome film employs a combination of layered thin film materials that create a crisp colour shift when the banknote viewing angle is changed. The film’s simplicity, durability, and impactful colour shift have made it a standard in document and currency authentication for over two decades. About Nanotech With billions of security features in circulation, Nanotech’s products include secure and memorable security labels, stripes, patches, and colour-shifting foils for currency authentication and brand protection. KolourOptik® is a patented visual technology that is exclusive to the government and banknote market and combines sub-wavelength nanostructures and microstructures to create modern overt security features with a unique and customizable optical effect. KolourOptik pure plasmonic colour pixels produce full colour, 3D depth, and movement used in security stripes and threads that are nearly impossible to replicate. LiveOptik™ is a patented visual technology that utilizes innovative nano-optics one tenth the size of traditional holographic structures to create next generation overt security features customized to our customers’ unique requirements. LiveOptik delivers multi-colour, 3D depth, movement, and image switches for secure brand protection stripes, threads, and labels that are nearly impossible to replicate. Additional information about Nanotech can be found at the Company’s website www.nanosecurity.ca, the Canadian disclosure filings website www.sedar.com or the OTCMarkets disclosure filings website www.otcmarkets.com. Nanotech Security Corp.:US Investor Relations:Canada Investor Relations:Kelley RyshakMatthew SelingerSean Peasgoodinfo@firstname.lastname@example.org@SophicCapital.com+1.604.678.5775+1.415.572.8152+1.647.699.9845 Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Singapore’s 11th integrated transport hub (ITH), Woodlands ITH, will open on 13 June, the Land Transport Authority (LTA) said on Monday (17 May).
Everything you need to know about the green list
The "Saudi Arabia Ready Meals Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.
Dublin, May 17, 2021 (GLOBE NEWSWIRE) -- The "Liquid Dietary Supplements Market by Ingredient, Application, Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering. The liquid dietary supplements market accounted for $21,685.72 million in 2019, and is expected to reach $27,732.27 million by 2027, registering a CAGR of 4.0% from 2020 to 2027.Liquid dietary supplements are nutritional supplements that are available in fluid form. They are usually consumed to enhance body metabolism and reduce occurrences of lifestyle disorders. Liquid dietary supplements are largely used by consumers that are unable to consume dietary supplements in capsule, thick gel, and solid tablet forms.According to the consumer survey of Council for Responsible Nutrition's (CRN), more than 70% women in the U.S. (around 113 million female consumers) prefer taking supplements on regular basis. The same survey reveals that top concerns for taking dietary supplements such as overall wellness accounts for 57%, bone health for 31% and healthy aging for 27%. Along with prominent shift of society toward preventive and healthier lifestyle, coupled with growth in consumers including children and aged population, choosing nutrition supplements in their daily routines are expected to propel growth of the global liquid dietary supplements market. However, fake product marketing and violation of regulations regarding label of products are anticipated to restrain growth of the liquid dietary supplements market.Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in 2019, and is expected to retain its dominance throughout the forecast period. This is attributed to factors such as presence of major market players in this region, which are introducing quality products to capture maximum market share. In addition, government support for research & development and availability of funds for research fuel the market growth. Moreover, the U.S. is the target area for top players in the market, owing to high awareness regarding dietary supplements devices. However, Asia-Pacific and LAMEA are expected to emerge as lucrative areas with maximum growth potential, owing to investments in new inventions, general economic conditions, increase in number of athletes and sports professionals, increase in the economy, and rise in health risks and diseases, which can be controlled by consumption of dietary supplements.The global liquid dietary supplements market is segmented on the basis of ingredient, application, distribution channel, and region. On the basis of ingredient, it is categorized into vitamins & minerals, botanical, proteins & amino acids and others. On the basis of application, it is categorized into bone & joint health, heart health, immune health, sports nutrition, weight loss, and others. On the basis of distribution channel, it is categorized into hypermarkets/supermarkets, health & beauty retail stores, drug stores, and online pharmacies & e-commerce sites. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, the UK, France, Spain, Italy, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).The key companies operating in the market include Abbott Laboratories, Bayer, Herbalife International, Koninklijke DSM, BASF, DuPont Nutrition & Biosciences, GlaxoSmithKline, Amway, Glanbia, Liquid Health, Inc.Key Benefits The study provides an in-depth analysis of the global liquid dietary supplements market along with the current trends and future estimations to elucidate the imminent investment pockets.It offers a quantitative analysis from 2019 to 2027, which is expected to enable stakeholders to capitalize on prevailing market opportunities.The key market players and their strategies have been analyzed to understand the competitive outlook of the global liquid dietary supplements market. Key Topics Covered: Chapter 1: Introduction Chapter 2: Executive Summary2.1. Key Findings of the Study2.2. Cxo PerspectiveChapter 3: Market Overview3.1. Market Definition and Scope3.2. Key Findings3.2.1. Top Player Positioning3.2.2. Top Investment Pockets3.2.3. Top Winning Strategies3.3. Porter's Five Forces Analysis3.4. Impact Analysis3.4.1. Drivers126.96.36.199. Healthy Aging and Proactive Consumption of Nutritional Interventions188.8.131.52. Rise in Adoption of Rtd (Ready-To-Drink) Dietary Supplements3.4.2. Restraint184.108.40.206. Stringent Rules and Regulations3.4.3. Opportunity220.127.116.11. High Growth Potential in Emerging Markets3.5. Impact of COVID-19 on Liquid Dietary Supplements MarketChapter 4: Liquid Dietary Supplements Market, by Ingredient4.1. Overview4.1.1. Market Size and Forecast4.2. Vitamins & Minerals4.2.1. Key Market Trends and Opportunities4.2.2. Market Size and Forecast, by Region4.3. Botanical4.3.1. Key Market Trends and Opportunities4.3.2. Market Size and Forecast, by Region4.4. Proteins & Amino Acids4.4.1. Key Market Trends and Opportunities4.4.2. Market Size and Forecast, by Region4.5. Others4.5.1. Key Market Trends and Opportunities4.5.2. Market Size and Forecast, by RegionChapter 5: Liquid Dietary Supplements Market, by Application5.1. Overview5.1.1. Market Size and Forecast5.2. Bone & Joint Health5.2.1. Key Market Trends and Opportunities5.2.2. Market Size and Forecast, by Region5.2.3. Market Analysis, by Country5.3. Heart Health5.3.1. Key Market Trends and Opportunities5.3.2. Market Size and Forecast, by Region5.3.3. Market Analysis, by Country5.4. Immune Health5.4.1. Key Market Trends and Opportunities5.4.2. Market Size and Forecast, by Region5.4.3. Market Analysis, by Country5.5. Sports Nutrition5.5.1. Key Market Trends and Opportunities5.5.2. Market Size and Forecast, by Region5.5.3. Market Analysis, by Country5.6. Weight Loss5.6.1. Key Market Trends and Opportunities5.6.2. Market Size and Forecast, by Region5.6.3. Market Analysis, by Country5.7. Digestive Health5.7.1. Key Market Trends and Opportunities5.7.2. Market Size and Forecast, by Region5.7.3. Market Analysis, by Country5.8. Others5.8.1. Key Market Trends and Opportunities5.8.2. Market Size and Forecast, by Region5.8.3. Market Analysis, by CountryChapter 6: Liquid Dietary Supplements Market, by Distribution Channel6.1. Overview6.1.1. Market Size and Forecast6.2. Hypermarket/Supermarket6.2.1. Market Size and Forecast, by Region6.2.2. Market Analysis, by Country6.3. Health and Beauty Retail Stores6.3.1. Market Size and Forecast, by Region6.3.2. Market Analysis, by Country6.4. DrU.S.ores6.4.1. Market Size and Forecast, by Region6.4.2. Market Analysis, by Country6.5. Online Pharmacies and E-Commerce Sites6.5.1. Market Size and Forecast, by Region6.5.2. Market Analysis, by CountryChapter 7: Liquid Dietary Supplements Market, by Region7.1. Overview7.2. North America7.3. Europe7.4. Asia-Pacific7.5. LAMEAChapter 8: Company Profiles8.1. Abbott Laboratories8.1.1. Company Overview8.1.2. Company Snapshot8.1.3. Operating Business Segments8.1.4. Product Portfolio8.1.5. Key Strategic Moves and Developments8.2. Bayer8.2.1. Company Overview8.2.2. Company Snapshot8.2.3. Operating Business Segments8.2.4. Product Portfolio8.3. Herbalife International8.3.1. Company Overview8.3.2. Company Snapshot8.3.3. Operating Business Segments8.3.4. Product Portfolio8.4. Koninklijke Dsm8.4.1. Company Overview8.4.2. Company Snapshot8.4.3. Operating Business Segments8.4.4. Product Portfolio8.4.5. Business Performance8.4.6. Key Strategic Moves and Developments8.5. Basf8.5.1. Company Overview8.5.2. Company Snapshot8.5.3. Operating Business Segments8.5.4. Product Portfolio8.5.5. Key Strategic Moves and Developments8.6. Dupont Nutrition & Biosciences8.6.1. Company Overview8.6.2. Company Snapshot8.6.3. Operating Business Segments8.6.4. Product Portfolio8.6.5. Business Performance8.7. GlaxoSmithKline8.7.1. Company Overview8.7.2. Company Snapshot8.7.3. Operating Business Segments8.7.4. Product Portfolio8.7.5. Business Performance8.8. Amway8.8.1. Company Overview8.8.2. Company Snapshot8.8.3. Operating Business Segments8.8.4. Product Portfolio8.8.5. Business Performance8.9. Glanbia8.9.1. Company Overview8.9.2. Company Snapshot8.9.3. Operating Business Segments8.9.4. Product Portfolio8.10. Liquid Health, Inc.8.10.1. Company Overview8.10.2. Company Snapshot8.10.3. Operating Business Segments8.10.4. Product PortfolioFor more information about this report visit https://www.researchandmarkets.com/r/9efk3v CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
London is on track for a £225 million spending boom this week from the return of hospitality, much needed for a city that has been battered by repeated lockdowns. Over the coming weeks, we will be walking a tightrope between opening up and containing infection jumps.
Turkey, Italy, Wales and Switzerland make up Group A
Hungary, Portugal, France and Germany make up Group F